| HIKMA PHARMACEUTICALS |
| Großbritannien |
| Gesundheit |
| GB00B0LCW083 / A0HG69 |
| H5P (Frankfurt) |
| FRA:H5P, ETR:H5P, H5P:GR |
| - |
| https://www.hikma.com/ |
|
Hikma Pharmaceuticals PLC is a leading global pharmaceutical company specializing in the development, manufacturing, and distribution of high-quality generic, branded, and specialty medicines. Founded over 45 years ago, it focuses on making essential..
>Volltext.. |
| 3815.84 Mio. EUR |
| 4890.81 Mio. EUR |
| 2969.17 Mio. EUR |
| 690.93 Mio. EUR |
| 357.52 Mio. EUR |
| 1.62 EUR |
| 1393.24 Mio. EUR |
| 284.9 Mio. EUR |
| 313.21 Mio. EUR |
| 0.24 |
| -1.45% |
| 3.09% |
| 0.72 EUR |
| 3.97% |
| 3.98% |
| 19.03.26 - 0.41515198€ 14.08.25 - 0.30888€ >weitere anzeigen... |
| - |
| HIKMA |
| 06.08.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|